Collaboration with Vanderbilt University
Boehringer Ingelheim and Vanderbilt University Announce Partnership to Develop Novel Therapies for Psychiatric Disorders Boehringer Ingelheim Enhances Central Nervous System Disease PipelineVanderbilt Center for Neuroscience Drug Discovery Advances Preclinical Schizophrenia Targets
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news